+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Non-melanoma Skin Cancer Market 2024-2028

  • PDF Icon

    Report

  • 145 Pages
  • July 2024
  • Region: Global
  • TechNavio
  • ID: 5578846
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The non-melanoma skin cancer market is forecasted to grow by USD 136.9 million during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the non-melanoma skin cancer market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by NMSC coverage and support, increase in awareness about skin cancer, and growing initiatives by organizations.

The non-melanoma skin cancer market is segmented as below:

By Type

  • BCC
  • SCC

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increasing incidence of NMSC as one of the prime reasons driving the non-melanoma skin cancer market growth during the next few years. Also, surgery considered as first-line curative approach for NMSC and high off-label use of topical treatments for NMSC will lead to sizable demand in the market.

The report on the non-melanoma skin cancer market covers the following areas:

  • Non-melanoma skin cancer market sizing
  • Non-melanoma skin cancer market forecast
  • Non-melanoma skin cancer market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading non-melanoma skin cancer market vendors that include 3M Co., Almirall SA, Amgen Inc., Bausch Health Companies Inc., Bristol Myers Squibb Co., Elekta AB, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline PLC, iCAD Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sensus Healthcare Inc., Sun Pharmaceutical Industries Ltd., Varian Medical Systems Inc., Viatris Inc., and Vidac Pharma. Also, the non-melanoma skin cancer market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Non-Melanoma Skin Cancer Market 2018 - 2022
Historic Market Size - Data Table on Global Non-Melanoma Skin Cancer Market 2018 - 2022 ($ million)
4.2 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
6.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
6.3 BCC - Market size and forecast 2023-2028
Chart on BCC - Market size and forecast 2023-2028 ($ million)
Data Table on BCC - Market size and forecast 2023-2028 ($ million)
Chart on BCC - Year-over-year growth 2023-2028 (%)
Data Table on BCC - Year-over-year growth 2023-2028 (%)
6.4 SCC - Market size and forecast 2023-2028
Chart on SCC - Market size and forecast 2023-2028 ($ million)
Data Table on SCC - Market size and forecast 2023-2028 ($ million)
Chart on SCC - Year-over-year growth 2023-2028 (%)
Data Table on SCC - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
7 Customer Landscape
7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
8.10 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.11 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
8.12 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
8.13 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints
10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business
11 Competitive Analysis
11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
3M Co.
3M Co. - Overview
3M Co. - Business segments
3M Co. - Key news
3M Co. - Key offerings
3M Co. - Segment focus
11.4 Almirall SA
Almirall SA - Overview
Almirall SA - Product / Service
Almirall SA - Key news
Almirall SA - Key offerings
11.5 Bausch Health Companies Inc.
Bausch Health Companies Inc. - Overview
Bausch Health Companies Inc. - Business segments
Bausch Health Companies Inc. - Key news
Bausch Health Companies Inc. - Key offerings
Bausch Health Companies Inc. - Segment focus
11.6 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
11.7 Elekta AB
Elekta AB - Overview
Elekta AB - Business segments
Elekta AB - Key offerings
Elekta AB - Segment focus
11.8 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
11.9 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product / Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
11.10 Varian Medical Systems Inc.
Varian Medical Systems Inc. - Overview
Varian Medical Systems Inc. - Product / Service
Varian Medical Systems Inc. - Key offerings
11.11 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
11.12 Vidac Pharma
Vidac Pharma - Overview
Vidac Pharma - Product / Service
Vidac Pharma - Key offerings
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
12.9 360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Company Market Positioning
Exhibits 9: Parent Market
Exhibits 10: Data Table on - Parent Market
Exhibits 11: Market characteristics analysis
Exhibits 12: Value Chain Analysis
Exhibits 13: Offerings of companies included in the market definition
Exhibits 14: Market segments
Exhibits 15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Historic Market Size - Data Table on Global Non-Melanoma Skin Cancer Market 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Type - Market share 2023-2028 (%)
Exhibits 31: Data Table on Type - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on BCC - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on BCC - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on BCC - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on BCC - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on SCC - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on SCC - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on SCC - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on SCC - Year-over-year growth 2023-2028 (%)
Exhibits 42: Market opportunity by Type ($ million)
Exhibits 43: Data Table on Market opportunity by Type ($ million)
Exhibits 44: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 45: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 46: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 47: Chart on Geographic comparison
Exhibits 48: Data Table on Geographic comparison
Exhibits 49: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 52: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 53: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 56: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 57: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 60: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 61: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 64: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 65: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 68: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 69: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 72: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 73: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 89: Market opportunity By Geographical Landscape ($ million)
Exhibits 90: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 91: Impact of drivers and challenges in 2023 and 2028
Exhibits 92: Overview on criticality of inputs and factors of differentiation
Exhibits 93: Overview on factors of disruption
Exhibits 94: Impact of key risks on business
Exhibits 95: Companies covered
Exhibits 96: Matrix on companies position and classification
Exhibits 97: 3M Co. - Overview
Exhibits 98: 3M Co. - Business segments
Exhibits 99: 3M Co. - Key news
Exhibits 100: 3M Co. - Key offerings
Exhibits 101: 3M Co. - Segment focus
Exhibits 102: Almirall SA - Overview
Exhibits 103: Almirall SA - Product / Service
Exhibits 104: Almirall SA - Key news
Exhibits 105: Almirall SA - Key offerings
Exhibits 106: Bausch Health Companies Inc. - Overview
Exhibits 107: Bausch Health Companies Inc. - Business segments
Exhibits 108: Bausch Health Companies Inc. - Key news
Exhibits 109: Bausch Health Companies Inc. - Key offerings
Exhibits 110: Bausch Health Companies Inc. - Segment focus
Exhibits 111: Bristol Myers Squibb Co. - Overview
Exhibits 112: Bristol Myers Squibb Co. - Product / Service
Exhibits 113: Bristol Myers Squibb Co. - Key news
Exhibits 114: Bristol Myers Squibb Co. - Key offerings
Exhibits 115: Elekta AB - Overview
Exhibits 116: Elekta AB - Business segments
Exhibits 117: Elekta AB - Key offerings
Exhibits 118: Elekta AB - Segment focus
Exhibits 119: F. Hoffmann La Roche Ltd. - Overview
Exhibits 120: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 121: F. Hoffmann La Roche Ltd. - Key news
Exhibits 122: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 123: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 124: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 125: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits 126: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits 127: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 128: Varian Medical Systems Inc. - Overview
Exhibits 129: Varian Medical Systems Inc. - Product / Service
Exhibits 130: Varian Medical Systems Inc. - Key offerings
Exhibits 131: Viatris Inc. - Overview
Exhibits 132: Viatris Inc. - Business segments
Exhibits 133: Viatris Inc. - Key news
Exhibits 134: Viatris Inc. - Key offerings
Exhibits 135: Viatris Inc. - Segment focus
Exhibits 136: Vidac Pharma - Overview
Exhibits 137: Vidac Pharma - Product / Service
Exhibits 138: Vidac Pharma - Key offerings
Exhibits 139: Inclusions checklist
Exhibits 140: Exclusions checklist
Exhibits 141: Currency conversion rates for US$
Exhibits 142: Research methodology
Exhibits 143: Information sources
Exhibits 144: Data validation
Exhibits 145: Validation techniques employed for market sizing
Exhibits 146: Data synthesis
Exhibits 147: 360 degree market analysis
Exhibits 148: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global non-melanoma skin cancer market: 3M Co., Almirall SA, Amgen Inc., Bausch Health Companies Inc., Bristol Myers Squibb Co., Elekta AB, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline PLC, iCAD Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sensus Healthcare Inc., Sun Pharmaceutical Industries Ltd., Varian Medical Systems Inc., Viatris Inc., and Vidac Pharma.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing incidence of NMSC."

According to the report, one of the major drivers for this market is the NMSC coverage and support.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 3M Co.
  • Almirall SA
  • Amgen Inc.
  • Bausch Health Companies Inc.
  • Bristol Myers Squibb Co.
  • Elekta AB
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • iCAD Inc.
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sensus Healthcare Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Varian Medical Systems Inc.
  • Viatris Inc.
  • Vidac Pharma